FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lars Farde

Research Profile

Procedures

Anatomy

Brain

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Jan D Andersson; Lars Farde; Patrick Raboisson; Nicholas Seneca; Phong Truong; David Wensbo; Christer Halldin
Palladium mediated (11)C-cyanation and characterization in the non-human primate brain of the novel mGluR5 radioligand [(11)C]AZD9272.
Joar Guterstam; Christer Halldin; Nitya Jayaram-Lindström; Simon Cervenka; Lars Farde; J James Frost; Johan Franck
Effects of amphetamine on the human brain opioid system--a positron emission tomography study.
Magnus Schou; Katarina Varnäs; Balázs Gulyás; Christer Halldin; Aurelija Jucaite; Lars Farde
Radiolabeling of the cannabinoid receptor agonist AZD1940 with carbon-11 and PET microdosing in non-human primate.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lars Farde (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jan D Andersson; Lars Farde; Patrick Raboisson; Nicholas Seneca; Phong Truong; David Wensbo; Christer Halldin
Palladium mediated (11)C-cyanation and characterization in the non-human primate brain of the novel mGluR5 radioligand [(11)C]AZD9272.
Nuclear medicine and biology 2013;40(4):547-53.
2013: Joar Guterstam; Christer Halldin; Nitya Jayaram-Lindström; Simon Cervenka; Lars Farde; J James Frost; Johan Franck
Effects of amphetamine on the human brain opioid system--a positron emission tomography study.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2013;16(4):763-9.
2013: Magnus Schou; Katarina Varnäs; Balázs Gulyás; Christer Halldin; Aurelija Jucaite; Lars Farde
Radiolabeling of the cannabinoid receptor agonist AZD1940 with carbon-11 and PET microdosing in non-human primate.
Nuclear medicine and biology 2013;40(3):410-4.
2013: Anton Forsberg; Yvonne Freund-Levi; Christer Halldin; Fredrik Jeppsson; Peter Johnström; Per Julin; Anders Juréus; Johan Sandell; Magnus Schou; Jan Andersson; Zsolt Cselényi; Maria Eriksdotter; Lars Farde; Britt-Marie Swahn; Katarina Varnäs; Samuel Svensson
Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients.
European journal of nuclear medicine and molecular imaging 2013;40(4):580-93.
2013: Fumitoshi Kodaka; Kazuhiko Nakayama; Takeshi Sasaki; Lars Farde; Saori Fujie; Hironobu Fujiwara; Christer Halldin; Hiroshi Ito; Yasuyuki Kimura; Harumasa Takano; Tetsuya Suhara
Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride.
European journal of nuclear medicine and molecular imaging 2013;40(4):574-9.
2013: Akihiro Takano; Christer Halldin; Lars Farde
SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study.
Psychopharmacology 2013;226(1):147-53.
2013: Örjan de Manzano; Simon Cervenka; Lars Farde; Oscar Hellenäs; Aurelija Jucaite; Fredrik Ullén
Individual differences in the proneness to have flow experiences are linked to dopamine D2-receptor availability in the dorsal striatum.
NeuroImage 2013;67():1-6.
2013: Martin Schain; Miklós Tóth; Ryosuke Arakawa; Zsolt Cselényi; Lars Farde; Christer Halldin; Andrea Varrone
Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRT.
European journal of nuclear medicine and molecular imaging 2013;40(2):228-37.
2012: Johan Lundberg; Mikael Tiger; Christer Halldin; Mikael Landén; Lars Farde
Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2012;15(8):1167-72.
2012: Sjoerd J Finnema; Christer Halldin; Tzung-Jeng Hwang; Andrea Varrone; Lars Farde
Confirmation of fenfluramine effect on 5-HT(1B) receptor binding of [(11)C]AZ10419369 using an equilibrium approach.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2012;32(4):685-95.
2012: Zsolt Cselényi; Anton Forsberg; Christer Halldin; Peter Johnström; Maria Eriksdotter Jönhagen; Per Julin; Magnus Schou; Samuel Svensson; Katarina Varnäs; Lars Farde
Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(3):415-24.
2012: Martin Schain; Per Stenkrona; Miklós Tóth; Zsolt Cselényi; Lars Farde; Christer Halldin; Andrea Varrone
Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems.
NeuroImage 2012;60(1):800-7.
2012: Ikuo Odano; Ivanka Savic; Andrea Varrone; Carolina Ciumas; Christer Halldin; Aurelija Jucaite; Per Karlsson; Lars Farde
Quantitative PET analyses of regional [11C]PE2I binding to the dopamine transporter--application to juvenile myoclonic epilepsy.
NeuroImage 2012;59(4):3582-93.
2012: Aurelija Jučaite; Per Julin; Per Stenkrona; Katarina Varnäs; Gabrielle Ahlberg; Jan Andersson; Annie Arvidsson; Zsolt Cselényi; Christer Halldin; Lars Farde
Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects.
EJNMMI research 2012;2():15.
2012: Robert A Comley; Lars Farde; Christer Halldin; Robert Y Lai; Julian C Matthews; Thomas E Nichols; Sven E Palhagen; Georgios Panagiotidis; Simon Cervenka; Brandon J Whitcher
A comparison of gray matter density in restless legs syndrome patients and matched controls using voxel-based morphometry.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 2012;22(1):28-32.
2011: Magdalena Nord; Svante Nyberg; Jacob Brogren; Christer Halldin; Aurelija Jucaite; Lars Farde
Comparison of D₂ dopamine receptor occupancy after oral administration of quetiapine fumarate immediate-release and extended-release formulations in healthy subjects.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2011;14(10):1357-66.
2011: Mouna Esmaeilzadeh; Lars Farde; Christer Halldin; Per Karlsson; Andrea Varrone; Susanna Waters; Joakim Tedroff
Extrastriatal dopamine D(2) receptor binding in Huntington's disease.
Human brain mapping 2011;32(10):1626-36.
2011: Lars Bäckman; Yvonne Brehmer; Lars Farde; Håkan Fischer; Per Karlsson; Sari Karlsson; Stuart W S MacDonald; Anna Rieckmann; Lars Nyberg
Dopamine D(1) receptors and age differences in brain activation during working memory.
Neurobiology of aging 2011;32(10):1849-56.
2011: Anna Rieckmann; Yvonne Brehmer; Lars Farde; Håkan Fischer; Per Karlsson; Sari Karlsson; Lars Nyberg; Lars Bäckman
Dopamine D1 receptor associations within and between dopaminergic pathways in younger and elderly adults: links to cognitive performance.
Cerebral cortex (New York, N.Y. : 1991) 2011;21(9):2023-32.
2011: Sari Karlsson; Lars Nyberg; Anna Rieckmann; Lars Farde; Per Karlsson; Lars Bäckman
Relationship of dopamine D1 receptor binding in striatal and extrastriatal regions to cognitive functioning in healthy humans.
NeuroImage 2011;57(2):346-51.
2011: Akihiro Takano; Balázs Gulyás; Christer Halldin; Sangram Nag; Lars Farde
NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primates in vivo.
Psychopharmacology 2011;216(2):279-86.
2011: Magdalena Nord; Lars Farde
Antipsychotic occupancy of dopamine receptors in schizophrenia.
CNS neuroscience & therapeutics 2011;17(2):97-103.
2011: Jan D Andersson; M Edward Pierson; Sjoerd J Finnema; Balázs Gulyás; Richard Heys; Charles S Elmore; Lars Farde; Christer Halldin
Development of a PET radioligand for the central 5-HT1B receptor: radiosynthesis and characterization in cynomolgus monkeys of eight radiolabeled compounds.
Nuclear medicine and biology 2011;38(2):261-72.
2011: Katarina Varnäs; Svante Nyberg; Per Karlsson; M Edward Pierson; Matts Kågedal; Zsolt Cselényi; Dennis McCarthy; Alan Xiao; Minli Zhang; Christer Halldin; Lars Farde
Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369.
Psychopharmacology 2011;213(2-3):533-45.
2011: Fumitoshi Kodaka; Hiroshi Ito; Harumasa Takano; Hidehiko Takahashi; Ryosuke Arakawa; Michie Miyoshi; Masaki Okumura; Tatsui Otsuka; Kazuhiko Nakayama; Christer Halldin; Lars Farde; Tetsuya Suhara
Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2011;14(1):83-9.
2011: Katarina Varnäs; Svante Nyberg; Christer Halldin; Andrea Varrone; Akihiro Takano; Per Karlsson; Jan Andersson; Dennis McCarthy; Mark Smith; M Edward Pierson; Johan Söderström; Lars Farde
Quantitative analysis of [11C]AZ10419369 binding to 5-HT1B receptors in human brain.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2011;31(1):113-23.
2010: Jan D Andersson; Katarina Varnäs; Zsolt Cselényi; Balázs Gulyás; David Wensbo; Sjoerd J Finnema; Britt-Marie Swahn; Samuel Svensson; Svante Nyberg; Lars Farde; Christer Halldin
Radiosynthesis of the candidate beta-amyloid radioligand [(11)C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys.
Synapse (New York, N.Y.) 2010;64(10):733-41.
2010: Anders Juréus; Britt-Marie Swahn; Johan Sandell; Fredrik Jeppsson; Allan E Johnson; Peter Johnström; Jan Neelissen; Dan Sunnemark; Lars Farde; Samuel P S Svensson
Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand.
Journal of neurochemistry 2010;114(3):784-94.
2010: S J Finnema; Andrea Varrone; T J Hwang; Balázs Gulyás; M E Pierson; Christer Halldin; Lars Farde
Fenfluramine-induced serotonin release decreases [11C]AZ10419369 binding to 5-HT1B-receptors in the primate brain.
Synapse (New York, N.Y.) 2010;64(7):573-7.
2010: Simon Cervenka; Andrea Varrone; Erik Fransén; Christer Halldin; Lars Farde
PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans.
Synapse (New York, N.Y.) 2010;64(6):478-85.
2010: Aurelija Jucaite; Hans Forssberg; Per Karlsson; Christer Halldin; Lars Farde
Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study.
Neuroscience 2010;167(1):104-10.
2010: Håkan Fischer; Lars Nyberg; Sari Karlsson; Per Karlsson; Yvonne Brehmer; Anna Rieckmann; Stuart W S MacDonald; Lars Farde; Lars Bäckman
Simulating neurocognitive aging: effects of a dopaminergic antagonist on brain activity during working memory.
Biological psychiatry 2010;67(6):575-80.
2010: Simon Cervenka; J Petter Gustavsson; Christer Halldin; Lars Farde
Association between striatal and extrastriatal dopamine D2-receptor binding and social desirability.
NeuroImage 2010;50(1):323-8.
2010: Orjan de Manzano; Simon Cervenka; Anke Karabanov; Lars Farde; Fredrik Ullén
Thinking outside a less intact box: thalamic dopamine D2 receptor densities are negatively related to psychometric creativity in healthy individuals.
PloS one 2010;5(5):e10670.
2009: Sari Karlsson; Lars Nyberg; Per Karlsson; Håkan Fischer; Petra Thilers; Stuart Macdonald; Yvonne Brehmer; Anna Rieckmann; Christer Halldin; Lars Farde; Lars Bäckman
Modulation of striatal dopamine D1 binding by cognitive processing.
NeuroImage 2009;48(2):398-404.
2009: Svante Nyberg; Maria Eriksdotter Jönhagen; Zsolt Cselényi; Christer Halldin; Per Julin; Hans Olsson; Yvonne Freund-Levi; Jan Andersson; Katarina Varnäs; Samuel Svensson; Lars Farde
Detection of amyloid in Alzheimer's disease with positron emission tomography using [11C]AZD2184.
European journal of nuclear medicine and molecular imaging 2009;36(11):1859-63.
2009: Andrea Varrone; Nils Sjöholm; Lars Eriksson; Balázs Gulyás; Christer Halldin; Lars Farde
Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT.
European journal of nuclear medicine and molecular imaging 2009;36(10):1639-50.
2009: Stuart W S MacDonald; Simon Cervenka; Lars Farde; Lars Nyberg; Lars Bäckman
Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning.
Neuropsychologia 2009;47(11):2299-304.
2009: Susanne Henningsson; Jacqueline Borg; Johan Lundberg; Jessica Bah; Mats Lindström; Erik Ryding; Hristina Jovanovic; Tomoyuki Saijo; Makoto Inoue; Ingmar Rosén; Lil Träskman-Bendz; Lars Farde; Elias Eriksson
Genetic variation in brain-derived neurotrophic factor is associated with serotonin transporter but not serotonin-1A receptor availability in men.
Biological psychiatry 2009;66(5):477-85.
2009: Jacqueline Borg; Susanne Henningsson; Tomoyuki Saijo; Makoto Inoue; Jessica Bah; Lars Westberg; Johan Lundberg; Hristina Jovanovic; Bengt Andrée; Anna-Lena Nordstrom; Christer Halldin; Elias Eriksson; Lars Farde
Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humans.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(6):783-92.
2009: Mats Larsson; Lars Farde; T Hummel; M Witt; N Erixon Lindroth; Lars Bäckman
Age-related loss of olfactory sensitivity: association to dopamine transporter binding in putamen.
Neuroscience 2009;161(2):422-6.
2009: Tatsui Otsuka; Hiroshi Ito; Christer Halldin; Hidehiko Takahashi; Harumasa Takano; Ryosuke Arakawa; Masaki Okumura; Fumitoshi Kodaka; Michie Miyoshi; Mizuho Sekine; Chie Seki; Ryuji Nakao; Kazutoshi Suzuki; Sjoerd Finnema; Yoshio Hirayasu; Tetsuya Suhara; Lars Farde
Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(5):703-10.
2009: Sjoerd J Finnema; Christer Halldin; Benny Bang-Andersen; Balázs Gulyás; Christoffer Bundgaard; Håkan V Wikström; Lars Farde
Dopamine D(2/3) receptor occupancy of apomorphine in the nonhuman primate brain--a comparative PET study with [11C]raclopride and [11C]MNPA.
Synapse (New York, N.Y.) 2009;63(5):378-89.
2009: Ikuo Odano; Christer Halldin; Per Karlsson; Andrea Varrone; Anu J Airaksinen; Raisa N Krasikova; Lars Farde
[18F]flumazenil binding to central benzodiazepine receptor studies by PET--quantitative analysis and comparisons with [11C]flumazenil.
NeuroImage 2009;45(3):891-902.
2009: Allan E Johnson; Fredrik Jeppsson; Johan Sandell; David Wensbo; Jan Neelissen; Anders Juréus; Peter Ström; Henrietta Norman; Lars Farde; Samuel P S Svensson
AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.
Journal of neurochemistry 2009;108(5):1177-86.
2009: Fiona McNab; Andrea Varrone; Lars Farde; Aurelija Jucaite; Paulina Bystritsky; Hans Forssberg; Torkel Klingberg
Changes in cortical dopamine D1 receptor binding associated with cognitive training.
Science (New York, N.Y.) 2009;323(5915):800-2.
2009: Magnus Schou; Sami S Zoghbi; H Umesha Shetty; Evgeny Shchukin; Jeih-San Liow; Jinsoo Hong; Bengt A Andrée; Balázs Gulyás; Lars Farde; Robert B Innis; Victor W Pike; Christer Halldin
Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2009;11(1):23-30.
2008: Simon Cervenka; Christer Halldin; Lars Farde
Age-related diurnal effect on D2 receptor binding: a preliminary PET study.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2008;11(5):671-8.
2008: Anu J Airaksinen; Sangram Nag; Sjoerd J Finnema; Jogeshwar Mukherjee; Sankha Chattopadhyay; Balázs Gulyás; Lars Farde; Christer Halldin
[11C]cyclopropyl-FLB 457: a PET radioligand for low densities of dopamine D2 receptors.
Bioorganic & medicinal chemistry 2008;16(13):6467-73.
2008: M Edward Pierson; Jan Andersson; Svante Nyberg; Dennis J McCarthy; Sjoerd J Finnema; Katarina Varnäs; Akihiro Takano; Per Karlsson; Balázs Gulyás; Amy M Medd; Chi-Ming Lee; Mark E Powell; J Richard Heys; William Potts; Nicholas Seneca; Ladislav Mrzljak; Lars Farde; Christer Halldin
[11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain.
NeuroImage 2008;41(3):1075-85.
2008: Jussi Hirvonen; Jarkko Johansson; Mika Teräs; Vesa Oikonen; Ville Lumme; Pauliina Virsu; Anne Roivainen; Kjell Någren; Christer Halldin; Lars Farde; Jarmo Hietala
Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2008;28(5):1059-69.
2008: Simon Cervenka; Lars Bäckman; Zsolt Cselényi; Christer Halldin; Lars Farde
Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum.
NeuroImage 2008;40(3):1287-95.
2008: Anna-Lena Nordstrom; Mattias Mansson; Hristina Jovanovic; Per Karlsson; Christer Halldin; Lars Farde; Kimberly E Vanover; Uli Hacksell; Mark R Brann; Robert E Davis; David M Weiner
PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brain.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2008;11(2):163-71.
2007: Johan Lundberg; Jacqueline Borg; Christer Halldin; Lars Farde
A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain.
Psychopharmacology 2007;195(3):425-33.
2007: Johan Lundberg; Jacob Strøyer Christophersen; Kamilla Buchberg Petersen; Henrik Loft; Christer Halldin; Lars Farde
PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(6):777-85.
2007: Andrew J Montgomery; Marie-Claude Asselin; Lars Farde; Paul M Grasby
Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2007;27(2):369-77.
2007: Magnus Schou; Victor W Pike; Judit Sóvágó; Balázs Gulyás; Peter T Gallagher; David Dobson; Magnus W Walter; Helene Rudyk; Lars Farde; Christer Halldin
Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.
Bioorganic & medicinal chemistry 2007;15(2):616-25.
2006: Mirjam Talvik; Anna-Lena Nordström; Yoshiro Okubo; Hans Olsson; Jacqueline Borg; Christer Halldin; Lars Farde
Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
Psychiatry research 2006;148(2-3):165-73.
2006: Zsolt Cselényi; Hans Olsson; Christer Halldin; Balázs Gulyás; Lars Farde
A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 and [11C]WAY 100635.
NeuroImage 2006;32(4):1690-708.
2006: Nicholas Seneca; Balázs Gulyás; Andrea Varrone; Magnus Schou; Anu Airaksinen; Johannes Tauscher; Francois Vandenhende; William Kielbasa; Lars Farde; Robert B Innis; Christer Halldin
Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.
Psychopharmacology 2006;188(1):119-27.
2006: Johan Lundberg; Christer Halldin; Lars Farde
Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility study.
Synapse (New York, N.Y.) 2006;60(3):256-63.
2006: Simon Cervenka; Sven E Pålhagen; Robert A Comley; Georgios Panagiotidis; Zsolt Cselényi; Julian C Matthews; Robert Y Lai; Christer Halldin; Lars Farde
Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.
Brain : a journal of neurology 2006;129(Pt 8):2017-28.
2006: Chi-Ming Lee; Lars Farde
Using positron emission tomography to facilitate CNS drug development.
Trends in pharmacological sciences 2006;27(6):310-6.
2006: Aurelija Jucaite; Ikuo Odano; Hans Olsson; Stefan Pauli; Christer Halldin; Lars Farde
Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study.
European journal of nuclear medicine and molecular imaging 2006;33(6):657-68.
2006: Jacqueline Borg; Bengt Andrée; Johan Lundberg; Christer Halldin; Lars Farde
Search for correlations between serotonin 5-HT1A receptor expression and cognitive functions--a strategy in translational psychopharmacology.
Psychopharmacology 2006;185(3):389-94.
2006: Nicholas Seneca; Sjoerd J Finnema; Lars Farde; Balázs Gulyás; Håkan V Wikström; Christer Halldin; Robert B Innis
Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.
Synapse (New York, N.Y.) 2006;59(5):260-9.
2006: Lars Bjerkenstedt; Lars Farde; Lars Terenius; Gunnar Edman; Nikolaos Venizelos; Frits-Axel Wiesel
Support for limited brain availability of tyrosine in patients with schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(2):247-55.
2006: Yuan-Hwa Chou; Christer Halldin; Lars Farde
Clozapine binds preferentially to cortical D1-like dopamine receptors in the primate brain: a PET study.
Psychopharmacology 2006;185(1):29-35.
2006: Lars Bäckman; Lars Nyberg; Ulman Lindenberger; Shu-Chen Li; Lars Farde
The correlative triad among aging, dopamine, and cognition: current status and future prospects.
Neuroscience and biobehavioral reviews 2006;30(6):791-807.
2006: Magnus Schou; Judit Sóvágó; Victor W Pike; Balázs Gulyás; Klaus P Bøgesø; Lars Farde; Christer Halldin
Synthesis and positron emission tomography evaluation of three norepinephrine transporter radioligands: [C-11]desipramine, [C-11]talopram and [C-11]talsupram.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(1):1-8.
2005: Christer Halldin; Johan Lundberg; Judit Sóvágó; Balázs Gulyás; Denis Guilloteau; Johnny Vercouillie; Patrick Emond; Sylvie Chalon; Jari Tarkiainen; Jukka Hiltunen; Lars Farde
[(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET.
Synapse (New York, N.Y.) 2005;58(3):173-83.
2005: Eva Lindström; Lars Farde; Jonas Eberhard; Wilhelm Haverkamp
QTc interval prolongation and antipsychotic drug treatments: focus on sertindole.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(4):615-29.
2005: Judit Sóvágó; Lars Farde; Christer Halldin; Evgenij Schukin; Magnus Schou; István Laszlovszky; Béla Kiss; Balázs Gulyás
Lack of effect of reserpine-induced dopamine depletion on the binding of the dopamine-D3 selective radioligand, [11C]RGH-1756.
Brain research bulletin 2005;67(3):219-24.
2005: Magnus Schou; Christer Halldin; Victor W Pike; P David Mozley; David Dobson; Robert B Innis; Lars Farde; Håkan Hall
Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2005;15(5):517-20.
2005: Johan Lundberg; Ikuo Odano; Hans Olsson; Christer Halldin; Lars Farde
Quantification of 11C-MADAM binding to the serotonin transporter in the human brain.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(9):1505-15.
2005: Anna Meschaks; Per Lindstrom; Christer Halldin; Lars Farde; Ivanka Savic
Regional reductions in serotonin 1A receptor binding in juvenile myoclonic epilepsy.
Archives of neurology 2005;62(6):946-50.
2005: Julie A McCarron; Sandrine Marchais-Oberwinkler; Victor W Pike; Jari Tarkiainen; Christer Halldin; Judit Sóvagó; Balàzs Gulyas; Håkan V Wikström; Lars Farde
Two C-methyl derivatives of [11C]WAY-100635--effects of an amido alpha-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2005;7(3):209-19.
2005: Sjoerd J Finnema; Nicholas Seneca; Lars Farde; Evgeny Shchukin; Judit Sóvágó; Balázs Gulyás; Håkan V Wikström; Robert B Innis; John L Neumeyer; Christer Halldin
A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey.
Nuclear medicine and biology 2005;32(4):353-60.
2005: Balázs Gulyás; Christer Halldin; Adám Vas; Richard B Banati; Evgeny Shchukin; Sjoerd Finnema; Jari Tarkainen; Karoly Tihanyi; Géza Szilágyi; Lars Farde
[11C]vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies.
Journal of the neurological sciences 2005;229-230():219-23.
2005: Hans Olsson; Lars Farde
Half-life of receptor occupancy--a meaningless concept.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(1):141-2.
2005: Aurelija Jucaite; Elisabeth Fernell; Christer Halldin; Hans Forssberg; Lars Farde
Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
Biological psychiatry 2005;57(3):229-38.
2005: Sandrine Marchais-Oberwinkler; Bartek Nowicki; Victor W Pike; Christer Halldin; Johan Sandell; Yuan-Hwa Chou; Balazs Gulyas; Lise T Brennum; Lars Farde; Håkan V Wikström
N-oxide analogs of WAY-100635: new high affinity 5-HT(1A) receptor antagonists.
Bioorganic & medicinal chemistry 2005;13(3):883-93.
2005: Nina Erixon-Lindroth; Lars Farde; Tarja-Brita Robins Wahlin; Judit Sovago; Christer Halldin; Lars Bäckman
The role of the striatal dopamine transporter in cognitive aging.
Psychiatry research 2005;138(1):1-12.
2004: Zsolt Cselényi; Johan Lundberg; Christer Halldin; Lars Farde; Balázs Gulyás
Joint explorative analysis of neuroreceptor subsystems in the human brain: application to receptor-transporter correlation using PET data.
Neurochemistry international 2004;45(5):773-81.
2004: Judit Sóvágó; Lars Farde; Christer Halldin; Oliver Langer; István Laszlovszky; Béla Kiss; Balázs Gulyás
Positron emission tomographic evaluation of the putative dopamine-D3 receptor ligand, [11C]RGH-1756 in the monkey brain.
Neurochemistry international 2004;45(5):609-17.
2004: Mirjam Talvik; Anna-Lena Nordström; Niels-Erik Larsen; Aurelija Jucaite; Simon Cervenka; Christer Halldin; Lars Farde
A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration.
Psychopharmacology 2004;175(2):148-53.
2004: Magnus Schou; Christer Halldin; Judit Sóvágó; Victor W Pike; Håkan Hall; Balázs Gulyás; P David Mozley; David Dobson; Evgeny Shchukin; Robert B Innis; Lars Farde
PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain.
Synapse (New York, N.Y.) 2004;53(2):57-67.
2004: Hans Olsson; Christer Halldin; Lars Farde
Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET.
NeuroImage 2004;22(2):794-803.
2004: Fumihiko Yasuno; Tetsuya Suhara; Yoshiro Okubo; Yasuhiko Sudo; Makoto Inoue; Tetsuya Ichimiya; Akihiro Takano; Kazuhiko Nakayama; Christer Halldin; Lars Farde
Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia.
The American journal of psychiatry 2004;161(6):1016-22.
2004: Ivanka Savic; Per Lindström; Balázs Gulyás; Christer Halldin; B Andrée; Lars Farde
Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy.
Neurology 2004;62(8):1343-51.
2004: Mattias Damberg; Cecilia Berggård; Lars Farde; Göran C Sedvall; Erik G Jönsson
Transcription factor AP-2beta genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humans.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(4):537-45.
2004: Thomas Balle; Christer Halldin; Linus Andersen; Lene Hjorth Alifrangis; Lassina Badolo; Klaus Gjervig Jensen; Yuan-Wha Chou; Kim Andersen; Jens Perregaard; Lars Farde
New alpha(1)-adrenoceptor antagonists derived from the antipsychotic sertindole - carbon-11 labelling and pet examination of brain uptake in the cynomolgus monkey.
Nuclear medicine and biology 2004;31(3):327-36.
2004: Christer Halldin; B Gulyás; Lars Farde
PET for drug development.
Ernst Schering Research Foundation workshop 2004;(48):95-109.
2004: Julie A McCarron; Victor W Pike; Christer Halldin; Johan Sandell; Judit Sóvágó; Balàsz Gulyas; Zsolt Cselényi; Håkan V Wikström; Sandrine Marchais-Oberwinkler; Bartek Nowicki; Frédéric Dollé; Lars Farde
The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivo.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2004;6(1):17-26.
2003: Mirjam Talvik; Anna-Lena Nordström; Hans Olsson; Christer Halldin; Lars Farde
Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2003;6(4):361-70.
2003: Jacqueline Borg; Bengt Andrée; Henrik Soderstrom; Lars Farde
The serotonin system and spiritual experiences.
The American journal of psychiatry 2003;160(11):1965-9.
2003: Victor W Pike; Christer Halldin; Kenji Nobuhara; Jukka Hiltunen; Rachel S Mulligan; Carl-Gunnar Swahn; Per Karlsson; Hans Olsson; Susan P Hume; Ella Hirani; Jaqueline Whalley; Lyn S Pilowsky; Stig Larsson; Per-Olof Schnell; Peter J Ell; Lars Farde
Radioiodinated SB 207710 as a radioligand in vivo: imaging of brain 5-HT4 receptors with SPET.
European journal of nuclear medicine and molecular imaging 2003;30(11):1520-8.
2003: Magnus Schou; Christer Halldin; Judit Sóvágó; Victor W Pike; Balázs Gulyás; P David Mozley; David P Johnson; Håkan Hall; Robert B Innis; Lars Farde
Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER.
Nuclear medicine and biology 2003;30(7):707-14.
2003: Christer Halldin; Nina Erixon-Lindroth; Stefan Pauli; Yuan-Hwa Chou; Yoshiro Okubo; Per Karlsson; Camilla Lundkvist; Hans Olsson; Denis Guilloteau; Patrick Emond; Lars Farde
[(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain.
European journal of nuclear medicine and molecular imaging 2003;30(9):1220-30.
2003: Andrea Carmine; Silvia Buervenich; Dagmar Galter; Erik G Jönsson; Göran C Sedvall; Lars Farde; J Petter Gustavsson; Hans Bergman; Kodavali V Chowdari; Vishwajit L Nimgaonkar; Maria Anvret; Olof Sydow; Lars Olson
NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2003;120B(1):51-7.
2003: Erik G Jönsson; Sven Cichon; J Petter Gustavsson; Frank Grünhage; Kaj Forslund; Marja Mattila-Evenden; Gunnar Rylander; Marie Asberg; Lars Farde; Peter Propping; Markus M Nöthen
Association between a promoter dopamine D2 receptor gene variant and the personality trait detachment.
Biological psychiatry 2003;53(7):577-84.
2003: Bengt Andrée; Ann Hedman; Seth-Olov Thorberg; Dag Nilsson; Christer Halldin; Lars Farde
Positron emission tomographic analysis of dose-dependent NAD-299 binding to 5-hydroxytryptamine-1A receptors in the human brain.
Psychopharmacology 2003;167(1):37-45.
2003: Andrea Carmine; Milan G Chheda; Erik G Jönsson; Göran C Sedvall; Lars Farde; J Petter Gustavsson; Hans Bergman; Maria Anvret; Silvia Buervenich; Lars Olson
Two NOTCH4 polymorphisms and their relation to schizophrenia susceptibility and different personality traits.
Psychiatric genetics 2003;13(1):23-8.
2003: Yuan-Hwa Chou; Christer Halldin; Lars Farde
Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study.
Psychopharmacology 2003;166(3):234-40.
2003: Sylvie Chalon; Jari Tarkiainen; Lucette Garreau; Håkan Hall; Patrick Emond; Johnny Vercouillie; Lars Farde; Philippe Dasse; Katarina Varnas; Jean-Claude Besnard; Christer Halldin; Denis Guilloteau
Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity.
The Journal of pharmacology and experimental therapeutics 2003;304(1):81-7.
2002: Balázs Gulyás; Christer Halldin; Johan Sandell; Per Karlsson; Judit Sóvágó; Egon Kárpáti; Béla Kiss; Adám Vas; Zsolt Cselényi; Lars Farde
PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects.
Acta neurologica Scandinavica 2002;106(6):325-32.
2002: Adám Vas; Judit Sóvágó; Christer Halldin; Johan Sandell; Per Karlsson; Egon Kárpáti; Béla Kiss; Zsolt Cselényi; Lars Farde; Balázs Gulyás
[Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study].
Orvosi hetilap 2002;143(47):2631-6.
2002: Balázs Gulyás; Adám Vas; Christer Halldin; Judit Sóvágó; Johan Sandell; Hans Olsson; Anna Fredriksson; Sharon Stone-Elander; Lars Farde
Cerebral uptake of [ethyl-11C]vinpocetine and 1-[11C]ethanol in cynomolgous monkeys: a comparative preclinical PET study.
Nuclear medicine and biology 2002;29(7):753-9.
2002: Zsolt Cselényi; Hans Olsson; Lars Farde; Balázs Gulyás
Wavelet-aided parametric mapping of cerebral dopamine D2 receptors using the high affinity PET radioligand [11C]FLB 457.
NeuroImage 2002;17(1):47-60.
2002: Johan Sandell; Christer Halldin; Judith Sovago; Yuan-Hwa Chou; Balázs Gulyás; Meixiang Yu; Patrick Emond; Kjell Någren; Denis Guilloteau; Lars Farde
PET examination of [(11)C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter.
Nuclear medicine and biology 2002;29(6):651-6.
2002: Balázs Gulyás; Christer Halldin; Judit Sóvágó; Johan Sandell; Zsolt Cselényi; Adám Vas; Béla Kiss; Egon Kárpáti; Lars Farde
Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.
European journal of nuclear medicine and molecular imaging 2002;29(8):1031-8.
2002: Svante Nyberg; Hans Olsson; Ulrika Nilsson; Eli Maehlum; Christer Halldin; Lars Farde
Low striatal and extra-striatal D2 receptor occupancy during treatment with the atypical antipsychotic sertindole.
Psychopharmacology 2002;162(1):37-41.
2002: Per Karlsson; Lars Farde; Christer Halldin; Göran C Sedvall
PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia.
The American journal of psychiatry 2002;159(5):761-7.
2002: Bengt Andrée; Christer Halldin; Victor W Pike; Roger Gunn; Hans Olsson; Lars Farde
The PET radioligand [carbonyl-(11)C]desmethyl-WAY-100635 binds to 5-HT(1A) receptors and provides a higher radioactive signal than [carbonyl-(11)C]WAY-100635 in the human brain.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(3):292-303.
2002: Håkan Hall; Katarina Varnäs; Johan Sandell; Christer Halldin; Lars Farde; Adám Vas; Egon Kárpáti; Balázs Gulyás
Autoradiographic evaluation of [11C]vinpocetine binding in the human postmortem brain.
Acta biologica Hungarica 2002;53(1-2):59-66.
2002: Johan Sandell; Christer Halldin; Yuan-Hwa Chou; Carl-Gunnar Swahn; Seth-Olov Thorberg; Lars Farde
PET-examination and metabolite evaluation in monkey of [(11)C]NAD-299, a radioligand for visualisation of the 5-HT(1A) receptor.
Nuclear medicine and biology 2002;29(1):39-45.
2002: Tetsuya Suhara; Yoshiro Okubo; Fumihiko Yasuno; Yasuhiko Sudo; Makoto Inoue; Tetsuya Ichimiya; Yoshifumi Nakashima; Kazuhiko Nakayama; Shuji Tanada; Kazutoshi Suzuki; Christer Halldin; Lars Farde
Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia.
Archives of general psychiatry 2002;59(1):25-30.
2001: Christer Halldin; B Gulyás; Lars Farde
PET studies with carbon-11 radioligands in neuropsychopharmacological drug development.
Current pharmaceutical design 2001;7(18):1907-29.
2001: Yasuhiko Sudo; Tetsuya Suhara; Makoto Inoue; Hiroshi Ito; Kazutoshi Suzuki; T Saijo; Christer Halldin; Lars Farde
Reproducibility of [11 C]FLB 457 binding in extrastriatal regions.
Nuclear medicine communications 2001;22(11):1215-21.
2001: Hans Olsson; Lars Farde
Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data.
NeuroImage 2001;14(4):936-45.
2001: Lars Bäckman; Lars Farde
Dopamine and cognitive functioning: brain imaging findings in Huntington's disease and normal aging.
Scandinavian journal of psychology 2001;42(3):287-96.
2001: Christer Halldin; Balázs Gulyás; O Langer; Lars Farde
Brain radioligands--state of the art and new trends.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2001;45(2):139-52.
2001: Mirjam Talvik; Anna-Lena Nordström; Svante Nyberg; Hans Olsson; Christer Halldin; Lars Farde
No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.
The American journal of psychiatry 2001;158(6):926-30.
2001: Hiroshi Ito; Y Sudo; T Suhara; Y Okubo; Christer Halldin; Lars Farde
Error analysis for quantification of [(11)C]FLB 457 binding to extrastriatal D(2) dopamine receptors in the human brain.
NeuroImage 2001;13(3):531-9.
2001: Johan Sandell; Christer Halldin; Victor W Pike; Yuan-Hwa Chou; Katarina Varnäs; Håkan Hall; S Marchais; Bartek Nowicki; Håkan V Wikström; Carl-Gunnar Swahn; Lars Farde
New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
Nuclear medicine and biology 2001;28(2):177-85.
2001: Valtteri Kaasinen; Kjell Någren; Jarmo Hietala; Lars Farde; Juha O Rinne
Sex differences in extrastriatal dopamine d(2)-like receptors in the human brain.
The American journal of psychiatry 2001;158(2):308-11.
2001: K Nobuhara; Lars Farde; Christer Halldin; Per Karlsson; Carl-Gunnar Swahn; Hans Olsson; Kim A Bergström; Stig A Larsson; Per-Olof Schnell; DW McPherson; A Savonen; Jukka Hiltunen; Göran C Sedvall
SPET imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNP.
European journal of nuclear medicine 2001;28(1):13-24.
2000: Håkan Hall; Lars Farde; Christer Halldin; Camilla Lundkvist; Göran C Sedvall
Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907.
Synapse (New York, N.Y.) 2000;38(4):421-31.
2000: O Langer; Christer Halldin; Y Chou; Johan Sandell; Carl-Gunnar Swahn; Kjell Någren; Roberto Perrone; Francesco Berardi; Marcello Leopoldo; Lars Farde
Carbon-11 pb-12: an attempt to visualize the dopamine d(4) receptor in the primate brain with positron emission tomography.
Nuclear medicine and biology 2000;27(8):707-14.
2000: Yuan-Hwa Chou; Christer Halldin; Lars Farde
Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study.
Synapse (New York, N.Y.) 2000;38(2):138-43.
2000: Valtteri Kaasinen; Harry Vilkman; Jarmo Hietala; Kjell Någren; Hans Helenius; H Olsson; Lars Farde; J Rinne
Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain.
Neurobiology of aging 2000;21(5):683-8.
2000: Bengt Andrée; Christer Halldin; Seth-Olov Thorberg; Johan Sandell; Lars Farde
Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development.
Nuclear medicine and biology 2000;27(5):515-21.
2000: Victor W Pike; Christer Halldin; Håkan V Wikström; S Marchais; Julie A McCarron; Johan Sandell; Bartek Nowicki; Carl-Gunnar Swahn; Safiye Osman; Susan P Hume; M Constantinou; Bengt Andrée; Lars Farde
Radioligands for the study of brain 5-HT(1A) receptors in vivo--development of some new analogues of way.
Nuclear medicine and biology 2000;27(5):449-55.
2000: Valtteri Kaasinen; Kjell Någren; Jarmo Hietala; Vesa Oikonen; Harry Vilkman; Lars Farde; Christer Halldin; Juha O Rinne
Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease.
Neurology 2000;54(7):1482-7.
2000: Lars Bäckman; N Ginovart; R A Dixon; Tarja-Brita Robins Wahlin; Ake Wahlin; Christer Halldin; Lars Farde
Age-related cognitive deficits mediated by changes in the striatal dopamine system.
The American journal of psychiatry 2000;157(4):635-7.
2000: Lars Farde; Bengt Andrée; N Ginovart; Christer Halldin; Seth-Olov Thorberg
PET-Determination of robalzotan (NAD-299) induced 5-HT(1A) receptor occupancy in the monkey brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(4):422-9.
2000: M Talvik-Lotfi; Svante Nyberg; Anna-Lena Nordström; H Ito; Christer Halldin; F Brunner; Lars Farde
High 5HT2A receptor occupancy in M100907-treated schizophrenic patients.
Psychopharmacology 2000;148(4):400-3.
2000: K Nobuhara; Christer Halldin; Håkan Hall; Per Karlsson; Lars Farde; Jukka Hiltunen; DW McPherson; A Savonen; Kim A Bergström; Stefan Pauli; Carl-Gunnar Swahn; Stig A Larsson; Per-Olof Schnell; Göran C Sedvall
Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's disease.
Psychopharmacology 2000;149(1):45-55.
2000: Svante Nyberg; Lars Farde
Non-equipotent doses partly explain differences among antipsychotics - implications of PET studies.
Psychopharmacology 2000;148(1):22-3.
1999: Y Okubo; H Olsson; H Ito; M Lofti; T Suhara; Christer Halldin; Lars Farde
PET mapping of extrastriatal D2-like dopamine receptors in the human brain using an anatomic standardization technique and [11C]FLB 457.
NeuroImage 1999;10(6):666-74.
1999: Kim A Bergström; Christer Halldin; A Savonen; Y Okubo; Jukka Hiltunen; K Nobuhara; Carl-Gunnar Swahn; Per Karlsson; D McPherson; Furn F Knapp; S Larsson; Per-Olof Schnell; Lars Farde
Iodine-123 labelled Z-(R,R)-IQNP: a potential radioligand for visualization of M(1 )and M(2) muscarinic acetylcholine receptors in Alzheimer's disease.
European journal of nuclear medicine 1999;26(11):1482-5.
1999: Balázs Gulyás; Christer Halldin; Per Karlsson; Y H Chou; Carl-Gunnar Swahn; P Bönöck; M Paróczai; Lars Farde
Brain uptake and plasma metabolism of [11C]vinpocetine: a preliminary PET study in a cynomolgus monkey.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 1999;9(4):217-22.
1999: Hans Olsson; Christer Halldin; Carl-Gunnar Swahn; Lars Farde
Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1999;19(10):1164-73.
1999: Yuan-Hwa Chou; Per Karlsson; Christer Halldin; Hans Olsson; Lars Farde
A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain.
Psychopharmacology 1999;146(2):220-7.
1999: Balázs Gulyás; Christer Halldin; Per Karlsson; Y H Chou; Carl-Gunnar Swahn; Péter Bönöczk; Lars Farde
[Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies].
Orvosi hetilap 1999;140(30):1687-91.
1999: O Langer; Christer Halldin; Frédéric Dollé; Carl-Gunnar Swahn; Hans Olsson; Per Karlsson; Håkan Hall; Johan Sandell; Camilla Lundkvist; Françoise Vaufrey; Christian Loc'h; Christian Crouzel; B Mazière; Lars Farde
Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors.
Nuclear medicine and biology 1999;26(5):509-18.
1999: Camilla Lundkvist; Christian Loc'h; Christer Halldin; Michel Bottlaender; Michèle Ottaviani; Christine Coulon; Chantal Fuseau; C Mathis; Lars Farde; B Mazière
Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporter.
Nuclear medicine and biology 1999;26(5):501-7.
1999: Julie Helfenbein; Johan Sandell; Christer Halldin; Sylvie Chalon; Patrick Emond; Y Okubo; Yuan-Hwa Chou; Yves Frangin; L Douziech; L Gareau; Carl-Gunnar Swahn; Jean-Claude Besnard; Lars Farde; Denis Guilloteau
PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter.
Nuclear medicine and biology 1999;26(5):491-9.
1999: Bengt Andrée; Seth-Olov Thorberg; Christer Halldin; Lars Farde
Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomography.
Psychopharmacology 1999;144(3):303-5.
1999: Svante Nyberg; B Eriksson; G Oxenstierna; Christer Halldin; Lars Farde
Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
The American journal of psychiatry 1999;156(6):869-75.
1999: Erik G Jönsson; Markus M Nöthen; Frank Grünhage; Lars Farde; Y Nakashima; Peter Propping; Göran C Sedvall
Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.
Molecular psychiatry 1999;4(3):290-6.
1999: Camilla Lundkvist; Christer Halldin; Carl-Gunnar Swahn; N Ginovart; Lars Farde
Different brain radioactivity curves in a PET study with [11C]beta-CIT labelled in two different positions.
Nuclear medicine and biology 1999;26(4):343-50.
1999: Johan Sandell; Christer Halldin; Håkan Hall; Seth-Olov Thorberg; T Werner; Daniel Sohn; Göran C Sedvall; Lars Farde
Radiosynthesis and autoradiographic evaluation of [11C]NAD-299, a radioligand for visualization of the 5-HT1A receptor.
Nuclear medicine and biology 1999;26(2):159-64.
1999: N Ginovart; Lars Farde; Christer Halldin; Carl-Gunnar Swahn
Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates.
Synapse (New York, N.Y.) 1999;31(2):154-62.
1999: H Ito; Y Okubo; Christer Halldin; Lars Farde
Mapping of central D2 dopamine receptors in man using [11C]raclopride: PET with anatomic standardization technique.
NeuroImage 1999;9(2):235-42.
1999: H Ito; Christer Halldin; Lars Farde
Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization technique.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(1):102-9.
1999: Håkan Hall; Christer Halldin; Denis Guilloteau; S Chalon; Patrick Emond; Jean-Claude Besnard; Lars Farde; G Sedvall
Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I.
NeuroImage 1999;9(1):108-16.
1998: Christer Halldin; C Foged; Yuan-Hwa Chou; Per Karlsson; Carl-Gunnar Swahn; Johan Sandell; Göran C Sedvall; Lars Farde
Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(12):2061-8.
1998: Håkan Hall; Christer Halldin; Lars Farde; Göran C Sedvall
Whole hemisphere autoradiography of the postmortem human brain.
Nuclear medicine and biology 1998;25(8):715-9.
1998: Lars Farde; H Ito; Carl-Gunnar Swahn; Victor W Pike; Christer Halldin
Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(11):1965-71.
1998: H Ito; J Hietala; G Blomqvist; Christer Halldin; Lars Farde
Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1998;18(9):941-50.
1998: Bengt Andrée; Svante Nyberg; H Ito; N Ginovart; F Brunner; F Jaquet; Christer Halldin; Lars Farde
Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain.
Journal of clinical psychopharmacology 1998;18(4):317-23.
1998: Anna-Lena Nordström; Lars Farde
Plasma prolactin and central D2 receptor occupancy in antipsychotic drug-treated patients.
Journal of clinical psychopharmacology 1998;18(4):305-10.
1998: C Foged; Christer Halldin; Carl-Gunnar Swahn; N Ginovart; Per Karlsson; Camilla Lundkvist; Lars Farde
[11C]NNC 22-0215, a metabolically stable dopamine D1 radioligand for PET.
Nuclear medicine and biology 1998;25(5):503-8.
1998: Patrick Emond; Lars Farde; Sylvie Chalon; Catherine Belzung; V Mauclaire; J P Chiron; Christer Halldin; Jean-Claude Besnard; Denis Guilloteau
Toxicity, mutagenicity, and behavioral effects of beta-CIT, a ligand for dopamine transporter exploration by SPECT.
Nuclear medicine and biology 1998;25(4):405-9.
1998: Jyrki T Kuikka; Jean-Louis Baulieu; Jukka Hiltunen; Christer Halldin; Kim A Bergström; Lars Farde; Patrick Emond; Sylvie Chalon; M Yu; T Nikula; T Laitinen; Jari Karhu; Erkki Tupala; Tero Hallikainen; V Kolehmainen; L Mauclaire; Bernard Maziere; Jari Tiihonen; Denis Guilloteau
Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging.
European journal of nuclear medicine 1998;25(5):531-4.
1998: Safiye Osman; Camilla Lundkvist; Victor W Pike; Christer Halldin; Julie A McCarron; Carl-Gunnar Swahn; Lars Farde; N Ginovart; Sajinder K Luthra; Roger Gunn; Christopher J Bench; Peter A Sargent; Paul M Grasby
Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
Nuclear medicine and biology 1998;25(3):215-23.
1998: Kim A Bergström; Christer Halldin; Jukka Hiltunen; Carl-Gunnar Swahn; H Ito; N Ginovart; Håkan Hall; DW McPherson; Furn F Knapp; S Larsson; Per-Olof Schnell; Lars Farde
Evaluation and metabolite studies of 125I- and 123I-labelled E-(R,R)-IQNP: potential radioligands for visualization of M1 muscarinic acetylcholine receptors in brain.
Nuclear medicine and biology 1998;25(3):209-14.
1998: Victor W Pike; Christer Halldin; Julie A McCarron; Camilla Lundkvist; Ella Hirani; Hans Olsson; Susan P Hume; Per Karlsson; Safiye Osman; Carl-Gunnar Swahn; Håkan Hall; Håkan V Wikström; M Mensonidas; K G Poole; Lars Farde
[carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
European journal of nuclear medicine 1998;25(4):338-46.
1998: Svante Nyberg; U Nilsson; Y Okubo; Christer Halldin; Lars Farde
Implications of brain imaging for the management of schizophrenia.
International clinical psychopharmacology 1998;13 Suppl 3():S15-20.
1998: Anna-Lena Nordström; Svante Nyberg; Hans Olsson; Lars Farde
Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients.
Archives of general psychiatry 1998;55(3):283-4.
1998: H Ito; Svante Nyberg; Christer Halldin; Camilla Lundkvist; Lars Farde
PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(1):208-14.
1998: Jukka Hiltunen; KK Akerman; Jyrki T Kuikka; Kim A Bergström; Christer Halldin; T Nikula; Pirkko Räsänen; Jari Tiihonen; M Vauhkonen; Jari Karhu; J Kupila; Esko Länsimies; Lars Farde
Iodine-123 labeled nor-beta-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography.
European journal of nuclear medicine 1998;25(1):19-23.
1997: Lars Farde
Brain imaging of schizophrenia--the dopamine hypothesis.
Schizophrenia research 1997;28(2-3):157-62.
1997: Lars Bäckman; Tarja-Brita Robins Wahlin; Anders Lundin; N Ginovart; Lars Farde
Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes.
Brain : a journal of neurology 1997;120 ( Pt 12)():2207-17.
1997: Lars Farde; T Suhara; Svante Nyberg; P Karlsson; Y Nakashima; J Hietala; Christer Halldin
A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients.
Psychopharmacology 1997;133(4):396-404.
1997: I Günther; Håkan Hall; Christer Halldin; Carl-Gunnar Swahn; Lars Farde; Göran C Sedvall
[125I] beta-CIT-FE and [125I] beta-CIT-FP are superior to [125I] beta-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brain.
Nuclear medicine and biology 1997;24(7):629-34.
1997: Camilla Lundkvist; Christer Halldin; N Ginovart; Carl-Gunnar Swahn; Lars Farde
[18F] beta-CIT-FP is superior to [11C] beta-CIT-FP for quantitation of the dopamine transporter.
Nuclear medicine and biology 1997;24(7):621-7.
1997: Svante Nyberg; Lars Farde; Christer Halldin
Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate. Preliminary findings.
Archives of general psychiatry 1997;54(10):953-8.
1997: C Foged; Christer Halldin; Christian Loc'h; B Mazière; Stefan Pauli; M Maziére; H C Hansen; T Suhara; Carl-Gunnar Swahn; Per Karlsson; Lars Farde
Bromine-76 and carbon-11 labelled NNC 13-8199, metabolically stable benzodiazepine receptor agonists as radioligands for positron emission tomography.
European journal of nuclear medicine 1997;24(10):1261-7.
1997: Lars Farde; N Ginovart; H Ito; Camilla Lundkvist; Victor W Pike; Julie A McCarron; Christer Halldin
PET-characterization of [carbonyl-11C]WAY-100635 binding to 5-HT1A receptors in the primate brain.
Psychopharmacology 1997;133(2):196-202.
1997: Håkan Hall; Christer Halldin; E Jerning; M Osterlund; Lars Farde; Göran C Sedvall
Autoradiographic comparison of [125I]epidepride and [125I]NCQ 298 binding to human brain extrastriated dopamine receptors.
Nuclear medicine and biology 1997;24(5):389-93.
1997: Bengt Andrée; Christer Halldin; M Vrijmoed-de Vries; Lars Farde
Central 5-HT2A and D2 dopamine receptor occupancy after sublingual administration of ORG 5222 in healthy men.
Psychopharmacology 1997;131(4):339-45.
1997: Kim A Bergström; Christer Halldin; Håkan Hall; Camilla Lundkvist; N Ginovart; Carl-Gunnar Swahn; Lars Farde
In vitro and in vivo characterisation of nor-beta-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain.
European journal of nuclear medicine 1997;24(6):596-601.
1997: N Ginovart; Lars Farde; Christer Halldin; Carl-Gunnar Swahn
Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.
Synapse (New York, N.Y.) 1997;25(4):321-5.
1997: Nora D Volkow; B Rosen; Lars Farde
Imaging the living human brain: magnetic resonance imaging and positron emission tomography.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(7):2787-8.
1997: N Ginovart; Anders Lundin; Lars Farde; Christer Halldin; Lars Bäckman; Carl-Gunnar Swahn; Stefan Pauli; Göran C Sedvall
PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.
Brain : a journal of neurology 1997;120 ( Pt 3)():503-14.
1997: Lars Farde; J Petter Gustavsson; E Jönsson
D2 dopamine receptors and personality traits.
Nature 1997;385(6617):590.
1997: Lars Farde; R J Mack; Svante Nyberg; Christer Halldin
D2 occupancy, extrapyramidal side effects and antipsychotic drug treatment: a pilot study with sertindole in healthy subjects.
International clinical psychopharmacology 1997;12 Suppl 1():S3-7.
1997: Håkan Hall; Camilla Lundkvist; Christer Halldin; Lars Farde; Victor W Pike; Julie A McCarron; A Fletcher; I A Cliffe; T Barf; Håkan V Wikström; Göran C Sedvall
Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635.
Brain research 1997;745(1-2):96-108.
1997: Svante Nyberg; Lars Farde
The relevance of serotonergic mechanisms in the treatment of schizophrenia has not been confirmed.
Journal of psychopharmacology (Oxford, England) 1997;11(1):13-4.
1997: Svante Nyberg; Lars Farde; Christer Halldin
A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;16(1):1-7.
1996: Håkan Hall; Christer Halldin; D Dijkstra; H Wikström; Lawrence D Wise; Thomas A Pugsley; Pierre Sokoloff; Stefan Pauli; Lars Farde; Göran C Sedvall
Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907.
Psychopharmacology 1996;128(3):240-7.
1996: S Nyberg; Lars Farde; Christer Halldin
Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients.
Psychiatry research 1996;67(3):163-71.
1996: C Foged; Christer Halldin; Christian Loc'h; B Mazière; Per Karlsson; M Mazière; Carl-Gunnar Swahn; Lars Farde
11C- and 76Br-labelled NNC 22-0010, selective dopamine D1 receptor radioligands for PET.
Nuclear medicine and biology 1996;23(6):837-44.
1996: Christian Loc'h; Christer Halldin; Michel Bottlaender; Carl-Gunnar Swahn; Rosa Maria Moresco; M Mazière; Lars Farde; B Mazière
Preparation of [76Br]FLB 457 and [76Br]FLB 463 for examination of striatal and extrastriatal dopamine D-2 receptors with PET.
Nuclear medicine and biology 1996;23(6):813-9.
1996: Safiye Osman; Camilla Lundkvist; Victor W Pike; Christer Halldin; Julie A McCarron; Carl-Gunnar Swahn; N Ginovart; Sajinder K Luthra; Christopher J Bench; Paul M Grasby; H Wikström; T Barf; I A Cliffe; A Fletcher; Lars Farde
Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET.
Nuclear medicine and biology 1996;23(5):627-34.
1996: Lars Farde; T Suhara; Christer Halldin; H Nybäck; Y Nakashima; Carl-Gunnar Swahn; Per Karlsson; N Ginovart; Frank P Bymaster; Harlan E Shannon; C Foged; PD Suzdak; Per Sauerberg
PET study of the M1-agonists [11C]xanomeline and [11C]butylthio-TZTP in monkey and man.
Dementia (Basel, Switzerland) 1996;7(4):187-95.
1996: Jyrki T Kuikka; Jukka Hiltunen; C Foged; Kim A Bergström; Christer Halldin; K Akerman; Jari Tiihonen; Lars Farde
Initial human studies with single-photon emission tomography using iodine-123 labelled 3-(5-cyclopropyl-1,2,4-oxadiazo-3-yl)- 7-iodo-5, 6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine (NNC 13-8241).
European journal of nuclear medicine 1996;23(7):798-803.
1996: Lars Farde
The advantage of using positron emission tomography in drug research.
Trends in neurosciences 1996;19(6):211-4.
1996: Håkan Hall; Lars Farde; Christer Halldin; Y L Hurd; Stefan Pauli; Göran C Sedvall
Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride.
Synapse (New York, N.Y.) 1996;23(2):115-23.
1996: Svante Nyberg; Y Nakashima; Anna-Lena Nordström; Christer Halldin; Lars Farde
Positron emission tomography of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response.
The British journal of psychiatry. Supplement 1996;(29):40-4.
1996: Christer Halldin; Lars Farde; Camilla Lundkvist; N Ginovart; Y Nakashima; Per Karlsson; Carl-Gunnar Swahn
[11C]beta-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography.
Synapse (New York, N.Y.) 1996;22(4):386-90.
1996: Kjell Någren; Christer Halldin; Carl-Gunnar Swahn; T Suhara; Lars Farde
[11C]metaraminol, a false neurotransmitter: preparation, metabolite studies and positron emission tomography examination in monkey.
Nuclear medicine and biology 1996;23(3):221-7.
1996: C Foged; Christer Halldin; Jukka Hiltunen; C Braestrup; C Thomsen; H C Hansen; T Suhara; Stefan Pauli; Carl-Gunnar Swahn; Per Karlsson; S Larsson; Lars Farde
Development of 123I-labelled NNC 13-8241 as a radioligand for SPECT visualization of benzodiazepine receptor binding.
Nuclear medicine and biology 1996;23(3):201-9.
1996: T Suhara; Lars Farde; Christer Halldin; K Någren; P Karlsson
Effects of cocaine on [11C]norepinephrine and [11C] beta-CIT uptake in the primate peripheral organs measured by PET.
Annals of nuclear medicine 1996;10(1):85-8.
1996: G Sedvall; Lars Farde
Dopamine receptors in schizophrenia.
Lancet 1996;347(8996):264.
1996: Camilla Lundkvist; Christer Halldin; N Ginovart; Svante Nyberg; Carl-Gunnar Swahn; A A Carr; F Brunner; Lars Farde
[11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography.
Life sciences 1996;58(10):PL 187-92.
1995: Kim A Bergström; Christer Halldin; J T Kuikka; Carl-Gunnar Swahn; J Tiihonen; Jukka Hiltunen; E Länsimies; Lars Farde
The metabolite pattern of [123I]beta-CIT determined with a gradient HPLC method.
Nuclear medicine and biology 1995;22(8):971-6.
1995: Simon M Ametamey; Christer Halldin; C G Swahn; Håkan Hall; P August Schubiger; Lars Farde
Synthesis of nor-beta-CIT, beta-CIT and trimethylstannyl-beta-CT.
Nuclear medicine and biology 1995;22(8):959-64.
1995: Lars Farde; Christer Halldin; Kjell Någren; Per Karlsson; Carl-Gunnar Swahn; T Suhara
PET examination of the monkey heart with high specific radioactivity [11C]norepinephrine and [11C]metaraminol.
Nuclear medicine and biology 1995;22(8):1053-6.
1995: Carl-Gunnar Swahn; Christer Halldin; Kjell Någren; Lars Farde
An HPLC-method for determination of ligand metabolism during PET studies with [11C]metaraminol and [11C]norepinephrine.
Nuclear medicine and biology 1995;22(8):1045-8.
1995: Svante Nyberg; Lars Farde; A Bartfai; Christer Halldin
Central D2 receptor occupancy and effects of zuclopenthixol acetate in humans.
International clinical psychopharmacology 1995;10(4):221-7.
1995: Per Karlsson; L Smith; Lars Farde; C Härnryd; Göran C Sedvall; Frits-Axel Wiesel
Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients.
Psychopharmacology 1995;121(3):309-16.
1995: Per Karlsson; Göran C Sedvall; Christer Halldin; Carl-Gunnar Swahn; Lars Farde
Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man.
Psychopharmacology 1995;121(3):300-8.
1995: Camilla Lundkvist; Christer Halldin; Carl-Gunnar Swahn; Håkan Hall; Per Karlsson; Y Nakashima; S Wang; R A Milius; J L Neumeyer; Lars Farde
[O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations.
Nuclear medicine and biology 1995;22(7):905-13.
1995: Anna-Lena Nordström; Lars Farde; Svante Nyberg; Per Karlsson; Christer Halldin; Göran C Sedvall
D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.
The American journal of psychiatry 1995;152(10):1444-9.
1995: Göran C Sedvall; Lars Farde
Chemical brain anatomy in schizophrenia.
Lancet 1995;346(8977):743-9.
1995: Svante Nyberg; Anna-Lena Nordström; Christer Halldin; Lars Farde
Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man.
International clinical psychopharmacology 1995;10 Suppl 3():81-5.
1995: Anna-Lena Nordström; Lars Farde; L Eriksson; Christer Halldin
No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.
Psychiatry research 1995;61(2):67-83.
1995: L Müller; Håkan Hall; Christer Halldin; Lars Farde; R Hohlweg; P D Suzdak; E B Nielsen; C Foged
Synthesis and binding properties of [3H]NNC 12-0781, a new radioligand for the dopamine reuptake system.
Nuclear medicine and biology 1995;22(6):711-7.
1995: Christer Halldin; Lars Farde; Thomas Högberg; Nina Mohell; Håkan Hall; T Suhara; Per Karlsson; Y Nakashima; Carl-Gunnar Swahn
Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1275-81.
1995: Lars Farde; Håkan Hall; Stefan Pauli; Christer Halldin
Variability in D2-dopamine receptor density and affinity: a PET study with [11C]raclopride in man.
Synapse (New York, N.Y.) 1995;20(3):200-8.
1995: Per Karlsson; Lars Farde; Christer Halldin; Göran C Sedvall; L Ynddal; M Sloth-Nielsen
Oral administration of NNC 756--a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man.
Psychopharmacology 1995;119(1):1-8.
1995: Kim A Bergström; Christer Halldin; Jyrki T Kuikka; Carl-Gunnar Swahn; Jari Tiihonen; Jukka Hiltunen; Esko Länsimies; Lars Farde
Lipophilic metabolite of [123I]beta-CIT in human plasma may obstruct quantitation of the dopamine transporter.
Synapse (New York, N.Y.) 1995;19(4):297-300.
1995: Håkan Hall; Christer Halldin; Svante Nyberg; Lars Farde; Göran C Sedvall
Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5(1):19-25.
1995: Svante Nyberg; Lars Farde; Christer Halldin; M L Dahl; L Bertilsson
D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate.
The American journal of psychiatry 1995;152(2):173-8.
1995: Lars Farde; Svante Nyberg; G Oxenstierna; Y Nakashima; Christer Halldin; B Ericsson
Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients.
Journal of clinical psychopharmacology 1995;15(1 Suppl 1):19S-23S.
1995: Göran C Sedvall; Stefan Pauli; Per Karlsson; Lars Farde; Anna-Lena Nordström; Svante Nyberg; Christer Halldin
PET imaging of neuroreceptors in schizophrenia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5 Suppl():25-30.
1995: Göran C Sedvall; Stefan Pauli; Lars Farde; Per Karlsson; Svante Nyberg; Anna-Lena Nordström
Recent developments in PET scan imaging of neuroreceptors in schizophrenia.
The Israel journal of psychiatry and related sciences 1995;32(1):22-9.
1995: Göran C Sedvall; Lars Farde; Håkan Hall; Christer Halldin; Per Karlsson; Anna-Lena Nordström; Svante Nyberg; Stefan Pauli
Utilization of radioligands in schizophrenia research.
Clinical neuroscience (New York, N.Y.) 1995;3(2):112-21.
1994: Håkan Hall; Göran C Sedvall; O Magnusson; J Kopp; Christer Halldin; Lars Farde
Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;11(4):245-56.
1994: Lars Farde; Anna-Lena Nordström; Svante Nyberg; Christer Halldin; Göran C Sedvall
D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients.
The Journal of clinical psychiatry 1994;55 Suppl B():67-9.
1994: Christer Halldin; Thomas Högberg; Lars Farde
Fluorine-18-labelled NCQ 115, a selective dopamine D-2 receptor ligand. Preparation and positron emission tomography.
Nuclear medicine and biology 1994;21(4):627-31.
1994: Kjell Någren; K O Schoeps; Christer Halldin; Carl-Gunnar Swahn; Lars Farde
Selective synthesis of racemic 1-11C-labelled norepinephrine, octopamine, norphenylephrine and phenylethanolamine using [11C]nitromethane.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1994;45(4):515-21.
1994: Lars Farde; Christer Halldin; Kjell Någren; T Suhara; Per Karlsson; K O Schoeps; Carl-Gunnar Swahn; D Bone
Positron emission tomography shows high specific uptake of racemic carbon-11 labelled norepinephrine in the primate heart.
European journal of nuclear medicine 1994;21(4):345-7.
1994: G Movin-Osswald; P Karlsson; M Hammarlund-Udenaes; Lars Farde
Influence of rate of administration of raclopride on akathisia and prolactin response.
Psychopharmacology 1994;114(2):248-56.
1994: Lars Farde; Christer Halldin; L Müller; T Suhara; Per Karlsson; Håkan Hall
PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain.
Synapse (New York, N.Y.) 1994;16(2):93-103.
1994: L Müller; Christer Halldin; C Foged; Per Karlsson; Håkan Hall; Carl-Gunnar Swahn; P D Suzdak; R Hohlweg; E B Nielsen; Lars Farde
Preparation of a potential positron emission tomographic radioligand for the dopamine transporter.
European journal of nuclear medicine 1994;21(2):131-7.
1994: Frits-Axel Wiesel; Anna-Lena Nordström; Lars Farde; B Eriksson
An open clinical and biochemical study of ritanserin in acute patients with schizophrenia.
Psychopharmacology 1994;114(1):31-8.
1994: Göran C Sedvall; Per Karlsson; Anders Lundin; Maria Anvret; T Suhara; Christer Halldin; Lars Farde
Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease.
European archives of psychiatry and clinical neuroscience 1994;243(5):249-55.
1994: Lars Farde; Stefan Pauli; J E Litton; Christer Halldin; J Neiman; Göran C Sedvall
PET-determination of benzodiazepine receptor binding in studies on alcoholism.
EXS 1994;71():143-53.
1993: Christer Halldin; C Foged; Lars Farde; Per Karlsson; K Hansen; F Grønvald; Carl-Gunnar Swahn; Håkan Hall; Göran C Sedvall
[11C]NNC 687 and [11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkey.
Nuclear medicine and biology 1993;20(8):945-53.
1993: K O Schoeps; Christer Halldin; Kjell Någren; Carl-Gunnar Swahn; Per Karlsson; Håkan Hall; Lars Farde
Preparation of [1-11C]dopamine, [1-11C]p-tyramine and [1-11C]m-tyramine. Autoradiography and PET examination of [1-11C]dopamine in primates.
Nuclear medicine and biology 1993;20(5):669-78.
1993: L Müller; Christer Halldin; Lars Farde; Per Karlsson; Håkan Hall; Carl-Gunnar Swahn; J Neumeyer; Y Gao; R Milius
[11C] beta-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations.
Nuclear medicine and biology 1993;20(3):249-55.
1993: J E Litton; J Neiman; Stefan Pauli; Lars Farde; T Hindmarsh; Christer Halldin; Göran C Sedvall
PET analysis of [11C]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls.
Psychiatry research 1993;50(1):1-13.
1993: Anna-Lena Nordström; Lars Farde; Frits-Axel Wiesel; K Forslund; Stefan Pauli; Christer Halldin; G Uppfeldt
Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.
Biological psychiatry 1993;33(4):227-35.
1993: Lars Farde; Anna-Lena Nordström
PET examination of central D2 dopamine receptor occupancy in relation to extrapyramidal syndromes in patients being treated with neuroleptic drugs.
Psychopharmacology series 1993;10():94-100.
1993: W Yisak; Lars Farde; C von Bahr; L B Nilsson; G Fredriksson; S Ogenstad
Interaction study between remoxipride and biperiden.
Psychopharmacology 1993;111(1):27-32.
1993: Per Karlsson; Lars Farde; Christer Halldin; Carl-Gunnar Swahn; Göran C Sedvall; C Foged; Kristian Tage Hansen; B Skrumsager
PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.
Psychopharmacology 1993;113(2):149-56.
1993: Anna-Lena Nordström; Lars Farde; Christer Halldin
High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET.
Psychopharmacology 1993;110(3):365-7.
1993: Svante Nyberg; Lars Farde; L Eriksson; Christer Halldin; B Eriksson
5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone.
Psychopharmacology 1993;110(3):265-72.
1992: Lars Farde; Anna-Lena Nordström; Frits-Axel Wiesel; Stefan Pauli; Christer Halldin; Göran C Sedvall
Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.
Archives of general psychiatry 1992;49(7):538-44.
1992: Lars Farde; Anna-Lena Nordström
PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients.
The British journal of psychiatry. Supplement 1992;(17):30-3.
1992: Håkan Hall; Lars Farde; Christer Halldin; Thomas Högberg; S Larsson; Göran C Sedvall
Imaging of dopamine receptors using PET and SPECT.
Neurochemistry international 1992;20 Suppl():329S-333S.
1992: G Movin-Osswald; A L Nordström; M Hammarlund-Udenaes; A Wahlén; Lars Farde
Pharmacokinetics of raclopride formulations. Influence of prolactin and tolerability in healthy male volunteers.
Clinical pharmacokinetics 1992;22(2):152-61.
1992: Lars Farde; Håkan Hall
Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands.
Arzneimittel-Forschung 1992;42(2A):260-4.
1992: Lars Farde
Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride.
Psychopharmacology 1992;107(1):23-9.
1992: Anna-Lena Nordström; Lars Farde; Christer Halldin
Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol.
Psychopharmacology 1992;106(4):433-8.
1992: C G Sedvall; Lars Farde; Håkan Hall; Christer Halldin; P Karlsson; S Brene; Nils Lindefors; H Persson; R E Chipkin; M Ehrlich
Ligand selection for PET studies of D1 dopamine receptors. Relationship between distribution of binding sites and mRNA for DAARPP32 in the human brain.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():466A-467A.
1992: Lars Farde; Anna-Lena Nordström; Christer Halldin; Frits-Axel Wiesel; Göran C Sedvall
PET studies of dopamine receptors in relation to antipsychotic drug treatment.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():468A-469A.
1992: Christer Halldin; Lars Farde; J E Litton; Håkan Hall; Göran C Sedvall
[11C]Ro 15-4513, a ligand for visualization of benzodiazepine receptor binding. Preparation, autoradiography and positron emission tomography.
Psychopharmacology 1992;108(1-2):16-22.
1992: Stefan Pauli; S Liljequist; Lars Farde; Carl-Gunnar Swahn; Christer Halldin; J E Litton; Göran C Sedvall
PET analysis of alcohol interaction with the brain disposition of [11C]flumazenil.
Psychopharmacology 1992;107(2-3):180-5.
1991: Christer Halldin; Lars Farde; Thomas Högberg; Håkan Hall; P Ström; A Ohlberger; O Solin
A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(8):871-81.
1991: Göran C Sedvall; Lars Farde; A Barnett; Håkan Hall; Christer Halldin
11C-SCH 39166, a selective ligand for visualization of dopamine-D1 receptor binding in the monkey brain using PET.
Psychopharmacology 1991;103(2):150-3.
1991: Håkan Hall; Thomas Högberg; Christer Halldin; C Köhler; P Ström; S B Ross; S A Larsson; Lars Farde
NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors.
Psychopharmacology 1991;103(1):6-18.
1991: L Eriksson; Lars Farde; G Rosenquist
Kinetic analysis of receptor binding with positron emission tomography.
Acta radiologica. Supplementum 1991;376():126-7.
1991: Christer Halldin; Lars Farde; Håkan Hall; Thomas Högberg; G Printz; W Pulka; Göran C Sedvall; O Solin
Synthesis of five benzamide analogs. Comparison with positron emission tomography.
Acta radiologica. Supplementum 1991;376():121-2.
1991: Christer Halldin; Lars Farde; A Barnett; Göran C Sedvall
Synthesis of carbon-11 labelled SCH 39166, a new selective dopamine D-1 receptor ligand, and preliminary PET investigations.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1991;42(5):451-5.
1990: Håkan Hall; I Wedel; Christer Halldin; J Kopp; Lars Farde
Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes.
Journal of neurochemistry 1990;55(6):2048-57.
1990: Lars Farde; Frits-Axel Wiesel; Sharon Stone-Elander; Christer Halldin; Anna-Lena Nordström; Håkan Hall; Göran C Sedvall
D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
Archives of general psychiatry 1990;47(3):213-9.
1990: Christer Halldin; Lars Farde; Thomas Högberg; Håkan Hall; G Sedvall
Carbon-11 labelling of eticlopride in two different positions--a selective high-affinity ligand for the study of dopamine D-2 receptors using PET.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1990;41(7):669-74.
1990: G Blomqvist; Stefan Pauli; Lars Farde; L Eriksson; A Persson; Christer Halldin
Maps of receptor binding parameters in the human brain--a kinetic analysis of PET measurements.
European journal of nuclear medicine 1990;16(4-6):257-65.
1990: Frits-Axel Wiesel; Lars Farde; Anna-Lena Nordström; Göran C Sedvall
Central D1- and D2-receptor occupancy during antipsychotic drug treatment.
Progress in neuro-psychopharmacology & biological psychiatry 1990;14(5):759-67.
1990: Lars Farde; C von Bahr
Distribution of remoxipride to the human brain and central D2-dopamine receptor binding examined in vivo by PET.
Acta psychiatrica Scandinavica. Supplementum 1990;358():67-71.
1990: W Yisak; C von Bahr; Lars Farde; M Grind; M Mattila; S Ogenstad
Drug interaction studies with remoxipride.
Acta psychiatrica Scandinavica. Supplementum 1990;358():58-62.
1990: Thomas Högberg; P Ström; Håkan Hall; C Köhler; Christer Halldin; Lars Farde
Syntheses of [123I]-, [125I]- and unlabelled (S)-3-iodo-5,6-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]salicylamide (NCQ 298), selective ligands for the study of dopamine D-2 receptors.
Acta pharmaceutica Nordica 1990;2(1):53-60.
1990: Göran C Sedvall; Lars Farde; H Nybäck; Stefan Pauli; A Persson; I Savic; Frits-Axel Wiesel
Recent advances in psychiatric brain imaging.
Acta radiologica. Supplementum 1990;374():113-5.
1989: Lars Farde; L Eriksson; G Blomquist; Christer Halldin
Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1989;9(5):696-708.
1989: Lars Farde; C von Bahr; A Wahlen; L Nilsson; M Widman
The new selective D2-dopamine receptor antagonist raclopride--pharmacokinetics, safety and tolerability in healthy males.
International clinical psychopharmacology 1989;4(2):115-26.
1989: Lars Farde; Frits-Axel Wiesel; L Nilsson; Göran C Sedvall
The potential of positron-emission tomography for pharmacokinetic and pharmacodynamic studies of neuroleptics.
Psychopharmacology series 1989;7():32-9.
1989: Frits-Axel Wiesel; Lars Farde; Christer Halldin
Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET.
Acta psychiatrica Scandinavica. Supplementum 1989;352():30-4.
1989: Lars Farde; Frits-Axel Wiesel; Anna-Lena Nordström; Göran C Sedvall
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics.
Psychopharmacology 1989;99 Suppl():S28-31.
1988: Lars Farde; Stefan Pauli; Håkan Hall; L Eriksson; Christer Halldin; Thomas Högberg; L Nilsson; I Sjögren; Sharon Stone-Elander
Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET.
Psychopharmacology 1988;94(4):471-8.
1988: Lars Farde; Frits-Axel Wiesel; P Jansson; G Uppfeldt; A Wahlen; Göran C Sedvall
An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET.
Psychopharmacology 1988;94(1):1-7.
1988: Göran C Sedvall; Lars Farde; Håkan Hall; Stefan Pauli; A Persson; Frits-Axel Wiesel
PET scanning--a new tool in clinical psychopharmacology.
Psychopharmacology series 1988;5():27-33.
1988: Håkan Hall; C Köhler; L Gawell; Lars Farde; G Sedvall
Raclopride, a new selective ligand for the dopamine-D2 receptors.
Progress in neuro-psychopharmacology & biological psychiatry 1988;12(5):559-68.
1988: N C Andreasen; R Carson; M Diksic; A Evans; Lars Farde; Albert Gjedde; A Hakim; S Lal; N Nair; G Sedvall
Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum.
Schizophrenia bulletin 1988;14(3):471-84.
1988: Håkan Hall; Lars Farde; G Sedvall
Human dopamine receptor subtypes--in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride.
Journal of neural transmission 1988;73(1):7-21.
1988: Lars Farde; M Grind; M I Nilsson; S Ogenstad; Göran C Sedvall
Remoxipride--a new potential antipsychotic drug. Pharmacological effects and pharmacokinetics following repeated oral administration in male volunteers.
Psychopharmacology 1988;95(2):157-61.
1988: Lars Farde; Frits-Axel Wiesel; Christer Halldin; Göran C Sedvall
Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.
Archives of general psychiatry 1988;45(1):71-6.
1987: J Borg; L Edström; Lars Bjerkenstedt; F A Wiesel; Lars Farde; L Hagenfeldt
Muscle biopsy findings, conduction velocity and refractory period of single motor nerve fibres in schizophrenia.
Journal of neurology, neurosurgery, and psychiatry 1987;50(12):1655-64.
1987: Olle Lindvall; E O Backlund; Lars Farde; G Sedvall; R Freedman; Barry Hoffer; A Nobin; A Seiger; Lars Olson
Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen.
Annals of neurology 1987;22(4):457-68.
1987: G Sedvall; Lars Farde; F A Wiesel
Quantitative determination of D2 dopamine receptor characteristics in healthy human subjects and psychiatric patients.
Life sciences 1987;41(7):813-6.
1987: Gerald Q Maguire; J Jaeger; Lars Farde; Marilyn E Noz
Use of graphical techniques for error evaluation.
Journal of medical systems 1987;11(4):277-86.
1987: Lars Farde; F A Wiesel; Håkan Hall; Christer Halldin; S Stone-Elander; G Sedvall
No D2 receptor increase in PET study of schizophrenia.
Archives of general psychiatry 1987;44(7):671-2.
1987: Lars Farde; Christer Halldin; S Stone-Elander; G Sedvall
PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.
Psychopharmacology 1987;92(3):278-84.
1987: Göran C Sedvall; H Nybäck; Lars Farde; A Persson
Neurotransmitter receptor imaging in Alzheimer's disease.
Journal of neural transmission. Supplementum 1987;24():43-8.
1986: G Sedvall; Lars Farde; A Persson; F A Wiesel
Imaging of neurotransmitter receptors in the living human brain.
Archives of general psychiatry 1986;43(10):995-1005.
1986: Lars Farde; Håkan Hall; E Ehrin; G Sedvall
Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.
Science (New York, N.Y.) 1986;231(4735):258-61.
1986: Christer Halldin; Sharon Stone-Elander; Lars Farde; E Ehrin; K J Fasth; B Långström; Göran C Sedvall
Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1986;37(10):1039-43.
1986: C Bohm; T Greitz; G Blomqvist; Lars Farde; P O Forsgren; D Kingsley; I Sjögren; Frits-Axel Wiesel; Gustav Wik
Applications of a computerized adjustable brain atlas in positron emission tomography.
Acta radiologica. Supplementum 1986;369():449-52.
1986: G Sedvall; Lars Farde; S Stone-Elander; Christer Halldin
Dopamine D1-receptor binding in the living human brain.
Advances in experimental medicine and biology 1986;204():119-24.
1985: Lars Farde; E Ehrin; L Eriksson; T Greitz; Håkan Hall; C G Hedström; J E Litton; Göran C Sedvall
Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(11):3863-7.
1985: E Ehrin; Lars Farde; T de Paulis; L Eriksson; T Greitz; P Johnström; J E Litton; J L Nilsson; Göran C Sedvall; Sharon Stone-Elander
Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey.
The International journal of applied radiation and isotopes 1985;36(4):269-73.
1985: A Persson; E Ehrin; L Eriksson; Lars Farde; C G Hedström; J E Litton; P Mindus; Göran C Sedvall
Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography.
Journal of psychiatric research 1985;19(4):609-22.
1984: Lars Farde; G Sedvall
[Swedish research in frontline. Positron emission tomography shows the brain's receptor functions in psychiatric diseases].
Läkartidningen 1984;81(48):4519-21.
1984: E Ehrin; P Johnström; Sharon Stone-Elander; J L Nilsson; A Persson; Lars Farde; Göran C Sedvall; J E Litton; L Eriksson; L Widén
Preparation and preliminary positron emission tomography studies of 11C-Ro 15-1788, a selective benzodiazepine receptor antagonist.
Acta pharmaceutica Suecica 1984;21(3):183-8.